Skip to main navigation Skip to search Skip to main content

Cost-Effectiveness Analysis of Ofatumumab versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A 10-Year Markov Model

  • Ziyad Saeed Almalki
  • , Mashael Mafleh Alshammari
  • , Saja H. Almazrou
  • , Ohud Abd Alhadi Alqahtani
  • , Maryam Riyadh Alkhayat
  • , Shahad Fahad Alnemari
  • , Haya Showky Mukhemair
  • , Sara Mohamaad Alkredeas
  • , Abdulrahman A. Alsuhibani
  • , Bushra Yousif Asiri
  • , Tala Nouraldin Alalawi
  • , Abdullah K. Alahmari
  • , Fahad Obaid Alotaibi
  • King Saud University
  • Almaarefa University
  • Qassim University
  • Ministry of Health, Saudi Arabia

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-Effectiveness Analysis of Ofatumumab versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A 10-Year Markov Model'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology